<?xml version="1.0" encoding="UTF-8"?>
<p>The combination of ChEs and/or BACE-1 inhibition with the activity on additional enzymatic/receptor systems and the effects on other AD-related alterations, such as metal dyshomeostasis and oxidative stress (
 <xref ref-type="fig" rid="fig4">Figure 4</xref>), opens up the way for the identification of very interesting MTDLs and represents the preferred approach for the discovery of new treatments.
</p>
